IGC Pharma reported its latest financial results, matching analyst expectations on earnings while revenue fell short of consensus forecasts.
IGC Pharma has released its financial results for the period, matching market expectations for earnings per share while missing revenue estimates.
Specific financial figures and details regarding the drivers behind the revenue shortfall were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
